Genomed Spólka Akcyjna (WSE:GEN)
Poland flag Poland · Delayed Price · Currency is PLN
28.60
+1.00 (3.62%)
At close: Jul 23, 2026

Genomed Spólka Akcyjna Balance Sheet

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
5.536.15.245.263.494.92
Cash & Short-Term Investments
5.536.15.245.263.494.92
Cash Growth
15.36%16.37%-0.37%50.81%-29.08%9.72%
Accounts Receivable
-2.831.531.721.31.12
Other Receivables
-0.170.070.060.160.15
Total Trade Receivables
3.5331.61.791.461.27
Inventory
1.742.042.142.022.071.24
Other Current Assets
0.270.480.210.360.240.16
Total Current Assets
11.0811.619.199.427.267.59
Net Property, Plant & Equipment
2.652.842.131.21.72.17
Other Intangible Assets
0.050.060.080.090.010.01
Long-Term Investments
---0.010.04-
Other Long-Term Assets
2.012.010.990.170.150.56
Total Assets
15.7916.5312.412.1210.3810.33
Accounts Payable
-0.80.480.950.40.81
Accrued Expenses
-1.060.810.760.620.5
Other Current Liabilities
-0.010.0200.020.01
Total Current Liabilities
1.352.041.311.711.041.32
Long-Term Debt
---0.010.020.04
Other Long-Term Liabilities
0.370.370.370.340.180.17
Total Long-Term Liabilities
0.370.370.370.350.20.21
Total Liabilities
1.722.411.682.061.241.53
Common Stock
-8.570.130.130.130.130.13
Treasury Stock
----1.22-1.22-
Additional Paid-in Capital
1.8810.599.4898.667.43
Retained Earnings
3.353.41.110.930.341.24
Shareholders' Equity
14.0714.1210.7210.069.138.8
Total Liabilities & Equity
15.7916.5312.412.1210.3810.33
Total Debt
-000.010.020.04
Net Cash (Debt)
5.536.15.245.263.474.88
Net Cash Growth
15.36%16.37%-0.25%51.58%-29.01%34.15%
Net Cash Per Share
4.184.623.973.982.623.70
Book Value
14.0714.1210.7210.069.138.8
Book Value Per Share
10.6510.688.117.616.916.66
Tangible Book Value
14.0214.0610.649.979.138.78
Tangible Book Value Per Share
10.6110.648.057.556.916.65